Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies.

Challa, Kiran; Paysan, Daniel; Leiser, Dominic; Sauder, Nadia; Weber, Damien C; Shivashankar, G V (2023). Imaging and AI based chromatin biomarkers for diagnosis and therapy evaluation from liquid biopsies. NPJ precision oncology, 7(1), p. 135. Springer Nature 10.1038/s41698-023-00484-8

Preview

Text s41698-023-00484-8.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (5MB) | Preview

Multiple genomic and proteomic studies have suggested that peripheral blood mononuclear cells (PBMCs) respond to tumor secretomes and thus could provide possible avenues for tumor prognosis and treatment evaluation. We hypothesized that the chromatin organization of PBMCs obtained from liquid biopsies, which integrates secretome signals with gene expression programs, provides efficient biomarkers to characterize tumor signals and the efficacy of proton therapy in tumor patients. Here, we show that chromatin imaging of PBMCs combined with machine learning methods provides such robust and predictive chromatin biomarkers. We show that such chromatin biomarkers enable the classification of 10 healthy and 10 pan-tumor patients. Furthermore, we extended our pipeline to assess the tumor types and states of 30 tumor patients undergoing (proton) radiation therapy. We show that our pipeline can thereby accurately distinguish between three tumor groups with up to 89% accuracy and enables the monitoring of the treatment effects. Collectively, we show the potential of chromatin biomarkers for cancer diagnostics and therapy evaluation.

Interest & Impact

Downloads

1 since deposited on 14 Dec 2023
1 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item